21 results
NOAC / DOAC Pharmacology and Prescribing Cheat Sheet
Novel (or Direct) Oral Anti-Coagulants
 • Rivaroxaban
 • Apixaban
NOAC / DOAC Pharmacology ... Prescribing Cheat Sheet Novel ... (or Direct) Oral ... #NOAC #DOAC #Pharmacology ... management #Direct #Oral
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents (DOACS ... #DOAC #Dosing #Oral
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
Direct-acting oral ... anticoagulants (DOACs ... Comparison Table #DOAC
Best practice recommendations for the diagnosis and treatment of adult patients experiencing traumatic brain injury during
treatment with oral ... Brain #Injury #NOAC ... #DOAC #Management
Pharmacokinetic Characteristics and Primary Routes of Clearance of Oral Anticoagulant Agents

Warfarin - 100% Hepatic, 0% Renal
Apixaban
of Clearance of Oral ... Hepatic, 35% Renal #DOAC ... #NOAC #Metabolism ... Pharmacology #Clearance #oral
How does the 2019 Novel Coronavirus (nCoV2019) compare to Ebola, SARS, MERS? Cases and Deaths
Weighing diseases
does the 2019 Novel ... Coronavirus (nCoV2019 ... into perspective. nCoV2019 ... to tell how far nCoV ... #Novel #Coronavirus
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
Fondaparinux, and Novel ... Oral Anticoagulants ... subcutaneous) and oral ... Heparins #LMWH #UFH #DOAC ... #Fondaparinux #NOAC
Criteria for Patients Under Investigation for 2019 Novel Coronavirus (2019-nCoV) / COVID-19

Fever or signs/symptoms of lower
Investigation for 2019 Novel ... Coronavirus (2019-nCoV ... laboratory-confirmed 2019-nCoV ... Investigation #Novel ... #Coronavirus #nCoV2019
Case Fatality Rate (CFR) and R0 of the Novel Coronavirus 2019 compared to other famous contagious
and R0 of the Novel ... Coronavirus #COVID19 #NCOV2019
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
direct-acting oral ... anticoagulants (DOACs ... filtration rate; DOAC ... direct-acting oral ... #DOAC #VTE #Malignancy